The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong anticoagulation therapy. However, the bleeding risk and recurrence of venous thromboembolism (VTE) in CTEPH patients who are administered warfarin have not been adequately evaluated. The purpose of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jujo-Sanada, Takayuki, Tanabe, Nobuhiro, Sakao, Seiichiro, Sugiura, Toshihiko, Sekine, Ayumi, Nishimura, Rintaro, Suda, Rika, Naito, Akira, Miwa, Hideki, Yamamoto, Keiko, Sasaki, Akane, Matsumura, Akane, Ema, Ryogo, Kasai, Hajime, Kato, Fumiaki, Tatsumi, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841905/
https://www.ncbi.nlm.nih.gov/pubmed/28604280
http://dx.doi.org/10.1177/2045893217717258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841905/
https://www.ncbi.nlm.nih.gov/pubmed/28604280
http://dx.doi.org/10.1177/2045893217717258

Ejemplares similares